Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)

Viruses. 2020 Jul 23;12(8):786. doi: 10.3390/v12080786.

Abstract

Camelpox is a viral contagious disease of Old-World camelids sustained by Camelpox virus (CMLV). The disease is characterized by mild, local skin or severe systemic infections and may have a major economic impact due to significant losses in terms of morbidity and mortality, weight loss, and low milk yield. Prevention of camelpox is performed by vaccination. In this study, we investigated the composition of a CMLV-based, live-attenuated commercial vaccine using next-generation sequencing (NGS) technology. The results of this analysis revealed genomic sequences of Modified Vaccinia virus Ankara (MVA).

Keywords: Vaccinia virus; camelpox; next-generation sequencing; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genome, Viral
  • High-Throughput Nucleotide Sequencing
  • Orthopoxvirus / genetics*
  • Phylogeny*
  • Vaccines, Attenuated / genetics
  • Vaccinia virus / genetics*
  • Viral Vaccines / genetics*
  • Whole Genome Sequencing*

Substances

  • Vaccines, Attenuated
  • Viral Vaccines